7 articles2,971 citations
Doxorubicin Alone versus Intensified Doxorubicin Plus Ifosfamide for First-Line Treatment of Advanced or Metastatic Soft-Tissue Sarcoma: A Randomised Controlled Phase 3 Trial
Judson, van der Graaf·Lancet Oncol·2014·1,181 citations
Survival and Prognosis with Osteosarcoma: Outcomes in More Than 2000 Patients in the EURAMOS-1 (european and American Osteosarcoma Study) Cohort.Citation only
Smeland, Marina·Eur J Cancer·2019·750 citations
Comparison of MAPIE versus MAP in Patients with a Poor Response to Preoperative Chemotherapy for Newly Diagnosed High-Grade Osteosarcoma (EURAMOS-1): An Open-Label, International, Randomised Controlled Trial.
Marina, Whelan·The Lancet. Oncology·2016·531 citations
Mesenchymal Chondrosarcoma: Prognostic Factors and Outcome in 113 Patients. A European Musculoskeletal Oncology Society Study.Citation only
Frezza, Whelan·Eur J Cancer·2015·180 citations
Comparison of Two Chemotherapy Regimens in Patients with Newly Diagnosed Ewing Sarcoma (EE2012): An Open-Label, Randomised, Phase 3 Trial.Citation only
Brennan, Wheatley·Lancet·2022·139 citations
Can Postoperative Radiotherapy Be Omitted in Localised Standard-Risk Ewing Sarcoma? An Observational Study of the Euro-E.w.i.n.g Group.Citation only
Foulon, Le Deley·Eur J Cancer·2016·95 citations
Neoadjuvant Chemotherapy with Doxorubicin and Cisplatin in Malignant Fibrous Histiocytoma of Bone: A European Osteosarcoma Intergroup Study.Citation only
Bramwell, Van Glabbeke·J Clin Oncol·1999·95 citations